A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 118, Issue 43, Pages e2108728118
Publisher
Proceedings of the National Academy of Sciences
Online
2021-10-12
DOI
10.1073/pnas.2108728118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein
- (2021) Mai Kishimoto et al. Viruses-Basel
- Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide
- (2021) Fei Li et al. Nature Communications
- Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
- (2021) Markus Hoffmann et al. EBioMedicine
- Global Protease Activity Profiling Identifies HER2-Driven Proteolysis in Breast Cancer
- (2021) Eugenia C. Salcedo et al. ACS Chemical Biology
- A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells
- (2021) Drake M. Mellott et al. ACS Chemical Biology
- The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways
- (2021) Manon Laporte et al. PLoS Pathogens
- The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
- (2021) Thomas P. Peacock et al. Nature Microbiology
- Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy
- (2021) Mona Sadat Mirtaleb et al. BIOMEDICINE & PHARMACOTHERAPY
- TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells
- (2021) Jana Koch et al. EMBO JOURNAL
- Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
- (2020) Markus Hoffmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
- (2020) Ruochen Zang et al. Science Immunology
- Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2
- (2020) James Brett Case et al. Cell Host & Microbe
- Candidate drugs against SARS-CoV-2 and COVID-19
- (2020) Dwight L. McKee et al. PHARMACOLOGICAL RESEARCH
- TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
- (2020) Dorothea Bestle et al. Life Science Alliance
- Targeting Proteases for Treating COVID-19
- (2020) Binquan Luan et al. JOURNAL OF PROTEOME RESEARCH
- COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response
- (2020) Sanchit Seth et al. Frontiers in Molecular Biosciences
- Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19
- (2020) Wen Cui et al. Frontiers in Molecular Biosciences
- Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2
- (2019) Vishnu C Damalanka et al. Future Medicinal Chemistry
- Cell surface–anchored serine proteases in cancer progression and metastasis
- (2019) Carly E. Martin et al. CANCER AND METASTASIS REVIEWS
- TMPRSS2 is the major activating protease of influenza A virus in primary human airway cells and influenza B virus in human type II pneumocytes
- (2019) Hannah Limburg et al. JOURNAL OF VIROLOGY
- Human matriptase/ST 14 proteolytically cleaves H7N9 hemagglutinin and facilitates the activation of influenza A/Shanghai/2/2013 virus in cell culture
- (2019) Gary R. Whittaker et al. Influenza and Other Respiratory Viruses
- Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology
- (2018) Vishnu C. Damalanka et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation
- (2017) Benjamin Y. Owusu et al. Oncotarget
- Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment
- (2017) Benjamin Owusu et al. Cancers
- α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer
- (2016) Zhenfu Han et al. ChemMedChem
- The role of type II transmembrane serine protease-mediated signaling in cancer
- (2016) Lauren M. Tanabe et al. FEBS Journal
- Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism
- (2016) Jung-Eun Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets
- (2015) Francisco M. Franco et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Influenza virus activating host proteases: Identification, localization and inhibitors as potential therapeutics
- (2015) Wolfgang Garten et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- The Host Protease TMPRSS2 Plays a Major Role in In Vivo Replication of Emerging H7N9 and Seasonal Influenza Viruses
- (2014) K. Sakai et al. JOURNAL OF VIROLOGY
- Inhibitors of HGFA, Matriptase, and Hepsin Serine Proteases: A Nonkinase Strategy to Block Cell Signaling in Cancer
- (2014) Zhenfu Han et al. ACS Medicinal Chemistry Letters
- The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis
- (2014) J. M. Lucas et al. Cancer Discovery
- Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research
- (2013) Graham Simmons et al. ANTIVIRAL RESEARCH
- Correlating Cell Line Studies With Tissue Distribution of DPP4/TMPRSS2 and Human Biological Samples May Better Define the Viral Tropism of MERS-CoV
- (2013) M. K.-S. Leow JOURNAL OF INFECTIOUS DISEASES
- Matriptase Proteolytically Activates Influenza Virus and Promotes Multicycle Replication in the Human Airway Epithelium
- (2013) A. Beaulieu et al. JOURNAL OF VIROLOGY
- TMPRSS2 Is an Activating Protease for Respiratory Parainfluenza Viruses
- (2013) M. Abe et al. JOURNAL OF VIROLOGY
- Effect of Signal Peptide on Stability and Folding of Escherichia coli Thioredoxin
- (2013) Pranveer Singh et al. PLoS One
- A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virus
- (2013) Dong-Hoon Chung et al. Virology Journal
- Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice
- (2013) Bastian Hatesuer et al. PLoS Pathogens
- Cleavage Activation of the Human-Adapted Influenza Virus Subtypes by Matriptase Reveals both Subtype and Strain Specificities
- (2012) B. S. Hamilton et al. JOURNAL OF VIROLOGY
- Matriptase, HAT, and TMPRSS2 Activate the Hemagglutinin of H9N2 Influenza A Viruses
- (2012) Joanna Baron et al. JOURNAL OF VIROLOGY
- Global identification of peptidase specificity by multiplex substrate profiling
- (2012) Anthony J O'Donoghue et al. NATURE METHODS
- Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts
- (2012) Stephanie Bertram et al. PLoS One
- Type II Transmembrane Serine Proteases
- (2009) Thomas H. Bugge et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enzymatic assembly of DNA molecules up to several hundred kilobases
- (2009) Daniel G Gibson et al. NATURE METHODS
- Type II transmembrane serine proteases in cancer and viral infections
- (2009) So-Young Choi et al. TRENDS IN MOLECULAR MEDICINE
- The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma
- (2008) JM Lucas et al. JOURNAL OF PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started